These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10856454)

  • 21. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia.
    Awaji T; Wu ZJ; Hashimoto K
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):869-78. PubMed ID: 8606522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y; Tanabe S; Nabuchi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias.
    Haruno A; Matsuzaki T; Hashimoto K
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):376-82. PubMed ID: 1700207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of a new antiarrhythmic drug, KW-3407, on canine ventricular arrhythmia models].
    Wu Z; Awaji T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):117-26. PubMed ID: 1427497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.
    Zhenjiu W; Awaji T; Hirasawa A; Motomura S; Hashimoto K
    Mol Cell Biochem; 1993 Feb; 119(1-2):159-69. PubMed ID: 8455577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of calcium channel blockers and antiarrhythmic drugs on digitalis-induced oscillatory afterpotentials on canine Purkinje fiber.
    Endou K; Yamamoto H; Sato T
    Jpn Heart J; 1987 Sep; 28(5):719-35. PubMed ID: 3430732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic profile of a new class 1 drug, AHR 10718, on canine atrial and ventricular arrhythmia models.
    Mitsuhashi H; Hashimoto K
    Jpn J Pharmacol; 1988 Apr; 46(4):349-58. PubMed ID: 3404765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
    Hashimoto K; Akiyama K; Mitsuhashi H
    Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models.
    Arita J; Xue YX; Aye NN; Fukuyama K; Wakui Y; Niitsu K; Maruno M; Siying C; Hashimoto K
    Eur J Pharmacol; 1996 Dec; 318(2-3):333-40. PubMed ID: 9016923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
    Hashimoto K; Matsuzaki T; Haruno A
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.
    Dong H; Sheng JZ; Lee CM; Wong TM
    Br J Pharmacol; 1993 May; 109(1):113-9. PubMed ID: 8495235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
    Hashimoto K; Ishii M; Komori S
    J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
    Nakamura M; Xue Y; Eto K; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
    Matsuzaki T; Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Feb; 231(3):363-70. PubMed ID: 8449229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
    Takada K; Sumikawa K; Kamibayashi T; Hayashi Y; Yamatodani A; Kawabata K; Yoshiya I
    Anesthesiology; 1993 Sep; 79(3):563-70. PubMed ID: 8363083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
    Akiyama K; Hashimoto K
    Jpn Heart J; 1989 Jul; 30(4):487-95. PubMed ID: 2509760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models.
    Komori S; Ishii M; Hashimoto K
    Jpn J Pharmacol; 1985 May; 38(1):73-82. PubMed ID: 4021230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
    Hashimoto K; Tsukada T; Matsuda H; Matsubara I; Imai S
    Jpn J Pharmacol; 1978 Aug; 28(4):535-44. PubMed ID: 32416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.